Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Isra Presisi Indonesia Tbk. (ISAP) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Isra Presisi Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Isra Presisi Indonesia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Isra Presisi Indonesia Tbk. trades at Rp25 (market cap 100.51B, 7.29M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 3.1× Isra Presisi Indonesia Tbk.'s market cap, and Isra Presisi Indonesia Tbk. is more actively traded (7.29M versus 41.7K). Which is the better fit depends on your goals.

DGNSISAP
Market Cap
316.25B100.51B
Volume
41.7K7.29M
Lot
41772.93K
Turnover
9.66M176.33M
Average Price
231.6524.18
Value
9.66M176.33M
Indicative Equilibrium Price
23025
Indicative Equilibrium Volume
2.4K1.51K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
ISAP
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Isra Presisi Indonesia Tbk.

PT Isra Presisi Indonesia Tbk ("The Company") was established on October 22, 2011 based on Notary Deed No. 47 of Evi Nursamsiyati, S.H. The Company started its commercial operations in2011.

Read more on ISAP